Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells

Immunology and Cell Biology

Volumn 85, Issue 8, 2007, Pages 610-616

  Roca, Leonarda ^a   Di Paolo, Salvatore ^b   Petruzzelli, Virna ^c   Grandaliano, Giuseppe ^c   Ranieri, Elena ^a   Schena, Francesco Paolo ^c   Gesualdo, Loreto ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Division of Nephrology and Dialysis   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Dendritic cells; Dexamethasone; IL 12; Immune response; MCP 1

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CELL DIFFERENTIATION; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNE RESPONSE; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

CHEMOKINE CCL2; DENDRITIC CELLS; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-12; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR2; TRANSFECTION;

EID: 36849062267     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100108     Document Type: Article

References (35)

1. Steinman RM. The dendritic cells system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296. Review.
2. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R et al. Reciprocal control of T helper cell and dendritic cells differentiation. Sciences 1999; 283: 1183-1186.
3. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18: 593-620.
4. Nagorsen D, Marincola FM, Panelli MC. Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays. Cytokine 2004; 25: 31-35.
5. Proost P, Wuyts A, Van Damme J. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59: 67-74.
6. Xu LL, Warren MK, Rose WL, Gong W, Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 1996; 60: 365-371.
7. Sozzani S, Rieppi M, Locati M, Zhou D, Bussolino F, Proost P et al. Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. Biochem Biophys Res Commun 1994; 199: 761-766.
8. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995; 154: 4166.
9. Fioretti F, Fradelizi D, Stoppacciaro A, Ramponi S, Ruco L, Minty A et al. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol 1998; 161: 342-346.
10. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155: 331-336.
11. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994; 179: 751.
12. Noso N, Proost P, Van Damme J, Schroder JM. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994; 200: 1470.
13. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117: 902-909.
14. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 1995; 25: 64.
15. Omata N, Yasutomi M, Yamada A, Iwasaki H, Mayumi M, Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response. J Immunol 2002; 169: 4861-4866.
16. Mosca PJ, Hobeika AC, Clay TM, Nair SK, Thomas EK, Morse MA et al. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood 2000; 96: 3499-3504.
17. Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone BE et al. Glucocorticoids affect human dendritic cells differentiation and maturation. J Immunol 1999; 162: 6473-6481.
18. 3 and glucocorticoid pathways. Biochem Biophys Res Commun 2002; 297: 645-652.
19. Park SK, Yang WS, Han NJ, Lee SK, Ahn H, Lee IK et al. Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endothelial cells. Nephrol Dial Transplant 2004; 19: 312-319.
20. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174: 134-141.
21. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, van Kooten C. The effect of calcineurin and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30: 1807-1812.
22. Sakai N, Furuichi K, Shimizu K, Wada T, Kokubo S, Hara A et al. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 2006; 79: 555-563.
23. de Haij S, Woltman AM, Bakker AC, Daha MR, van Kooten C. Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol 2002; 137: 197-204.
24. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000; 23: 407-411.
25. Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000; 22: 345-369. Review.
26. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. Leukoc Biol 1999; 66: 252-262.
27. Li LB, Leung DY, Hall CF, Goleva E. Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. J Leukoc Biol 2006; 79: 818-827.
28. Zhao Q, Wang X, Nelin LD et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006; 203: 131-140.
29. Baltathakis I, Alcantara O, Boldt DH. Expression of different NF-κB pathway genes in dendritic cells (DC) or macrophages assessed by gene expression profiling. J Cell Biochem 2001; 83: 281-290.
30. Zilberfarb V, Siquier K, Strosberg AD, Issad T. Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor-alpha expression in human PAZ6 cells. Diabetologia 2001; 44: 377-386.
31. Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005; 106: 3888-3894.
32. Schwarz M, Wahl M, Resch, Radeke HH. IFNgamma induces functional chemokine receptor expression in human mesangial cells. Clin Exp Immunol 2002; 128: 285-294.
33. Bette M, Jin SC, Germann T, Schäfer MK, Weihe E, Rüde E et al. Differential expression of mRNA encoding interleukin-12 p35 and p40 subunits in situ. Eur J Immunol 1994; 24: 2435-2440.
34. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effect of interleukin-10 on dendritic cells maturation and function. Eur J Immunol 1997; 27: 1229-1235.
35. Xia CQ, Peng R, Beato F, Clare-Salzer MJ. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scandin J Immunol 2005; 62: 45-54.